Information about Flindr Therapeutics
My details
*
*
*

Flindr Therapeutics (BV)

Company information

Status
Active

KVK number

77542649

VAT Number

NL 861040879 B01
Established
05-03-2020
Last balance sheet year
2025
Company size
Medium-sized 1 FTE
Legal form
Besloten Vennootschap (BV)
RSIN number
861040879
Principal activity
Research and experimental development on natural sciences and engineering
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Flindr Therapeutics

2025 2024 2023 2022
Balance sheet
Balance sheet total € 3.119.618 -70% € 10.321.607 931% € 1.000.725 -7% € 1.073.012
Equity € 2.448.040 -74% € 9.586.661 > 1000% € -354.348 -539% € -55.424
Debts € 671.578 -9% € 734.946 -46% € 1.355.073 20% € 1.128.436
Other
Employees 0 0 1 1

Frequently asked questions

What is the KVK number of Flindr Therapeutics?
The KVK number of Flindr Therapeutics is 77542649
What is the VAT number of Flindr Therapeutics?
The VAT number of Flindr Therapeutics is NL 861040879 B01.
Wat is the PEPPOL ID of Flindr Therapeutics?
The PEPPOL ID of Flindr Therapeutics is 0106:77542649. Log in or start a free trial to see the full overview.
When was Flindr Therapeutics founded?
Flindr Therapeutics was founded on 05-03-2020.
What is the address of Flindr Therapeutics?
The current registered office of Flindr Therapeutics is located at Kloosterstraat 9/RK, 5349 AB Oss.
When was the last time Flindr Therapeutics filed their annual financial statements?
The most recent financial statements of Flindr Therapeutics were filed on 31-12-2025.
How many employees does Flindr Therapeutics have?
There are 1 FTEs working at Flindr Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Flindr Therapeutics?
There is no turnover available for Flindr Therapeutics.